In addition, PITX2 enhanced the ABC drug resistance of colon cancer cells via inversely regulating the human OCT3 (gene, Slc22a3) protein and ATP-binding cassette drug transporters [25]. This evidence concerns the gene SLC22A3 and colonic neoplasm.